Eiger BioPharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Eiger BioPharmaceuticals's estimated annual revenue is currently $16.9M per year.
- Eiger BioPharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Eiger BioPharmaceuticals has 109 Employees.
- Eiger BioPharmaceuticals grew their employee count by 5% last year.
Eiger BioPharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Quality Assurance | Reveal Email/Phone |
3 | Head Analytical Development and QC | Reveal Email/Phone |
4 | VP Clinical Operations | Reveal Email/Phone |
5 | VP, Clinical Strategy | Reveal Email/Phone |
6 | SVP, Metabolic Diseases | Reveal Email/Phone |
7 | SVP, Clinical Development | Reveal Email/Phone |
8 | SVP, Clinical & Development Operations | Reveal Email/Phone |
9 | Senior Director, Operations | Reveal Email/Phone |
10 | Associate Director Clinical Operations | Reveal Email/Phone |
Eiger BioPharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Eiger BioPharmaceuticals?
Eiger Inc is a research company based out of 55 2Nd St, San Francisco, CA, United States.
keywords:N/A
N/A
Total Funding
109
Number of Employees
$16.9M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Eiger BioPharmaceuticals News
2022-04-17 - Eiger BioPharmaceuticals Strengthens Leadership Team with ...
Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments. Published: Apr 18, 2022. Chris Kurtz Appointed Chief Technical Officer...
2022-04-17 - Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Short Interest ...
Eiger BioPharmaceuticals, Inc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted...
2022-04-06 - Eiger Biopharmaceuticals: Value Inflection For Lead Asset In HDV Infection
On The Horizon
Eiger Biopharmaceuticals: Value Inflection For Lead Asset In HDV Infection On The Horizon. Apr. 06, 2022 2:48 PM ETEiger BioPharmaceuticals, Inc. (EIGR)5...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.3M | 109 | -2% | $162.8M |
#2 | $15.8M | 109 | 7% | N/A |
#3 | $15.3M | 109 | 0% | $16.7M |
#4 | $7.1M | 109 | -42% | $510M |
#5 | $36M | 109 | -17% | $15M |